Evidence map›Paper›PMID 41599750›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

UHPLC-Q-Orbitrap-HRMS-Based Multilayer Mapping of the Pharmacodynamic Substance Basis and Mechanistic Landscape of Maizibizi Wan in Chronic Nonbacterial Prostatitis Therapy.

Maimaitiming Maihemuti, Muaitaer Nuermaimaiti, Wuermaitihan Maimaitiming, Alimujiang Paierhati, Hailong Ji, Muhammatjan Abduwaki, Xinzhou Yang, Nabijan Mohammadtursun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maimaitiming MaihemutiXinjiang Key Laboratory of Hetian Characteristic Chinese Traditional Medicine Research, Xinjiang Hetian College, Hetian 848000, China.
Muaitaer NuermaimaitiXinjiang Key Laboratory of Hetian Characteristic Chinese Traditional Medicine Research, Xinjiang Hetian College, Hetian 848000, China.
Wuermaitihan MaimaitimingXinjiang Key Laboratory of Hetian Characteristic Chinese Traditional Medicine Research, Xinjiang Hetian College, Hetian 848000, China.
Alimujiang PaierhatiXinjiang Key Laboratory of Hetian Characteristic Chinese Traditional Medicine Research, Xinjiang Hetian College, Hetian 848000, China.
Hailong JiXinjiang Key Laboratory of Hetian Characteristic Chinese Traditional Medicine Research, Xinjiang Hetian College, Hetian 848000, China.
Muhammatjan AbduwakiXinjiang Key Laboratory of Hetian Characteristic Chinese Traditional Medicine Research, Xinjiang Hetian College, Hetian 848000, China.
Xinzhou YangSchool of Pharmacy, South-Central University for Nationalities, Wuhan 430074, China.ORCID 0000-0003-1697-2923
Nabijan MohammadtursunXinjiang Key Laboratory of Hetian Characteristic Chinese Traditional Medicine Research, Xinjiang Hetian College, Hetian 848000, China.ORCID 0009-0004-6155-5103

Funding

Natural Science Foundation of Xinjiang Uygur Autonomous Region 2025D01C346Open Lab Projects of Xinjiang Key Laboratory of Hotan Characteristice Chinese Traditional Med-icine Research 2025HCTMR06ZResearch and Development Plan Project of Hetian District, China 202425, 20221011Tianshan Talents Project of Xinjiang Uygur Autonomous Region 2023TSYCJC0048
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

blood-absorbable componentschronic non-bacterial prostatitisGNPSMaizibiziwanmolecular dockingnetwork pharmacologyUHPLC-Q-Orbitrap-HRMS

Identifiers

PMID41599750
PMCPMC12845146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.